From electrophysiological exploration to management of heart arrhythmias: economic analysis of practices in a high-volume French hospital over two different time periods.

Summary Background Medical devices (MD) used to treat arrhythmias range from electrophysiological exploration catheters to intracardiac ablation catheters, and they are continuously undergoing optimization. The inclusion of innovative MD in Diagnosis Related Groups (DRG) of the French healthcare economic system can lead to financial imbalance for health institutions. The objective of this study was to compare cost-revenue analyses for interventional heart rhythm management in a high-volume French hospital between two time periods. Methods For 3 months in 2014 and 3 months in 2017, all of the patients admitted to the interventional rhythmic unit with arrhythmia were included retrospectively in this monocenter study. All arrhythmias were considered. The primary clinical endpoint was the difference between the expenses and incomes, calculated for each patient. The secondary endpoint was the breakdown of costs. Results 217 patients were included. In 2014 period, the analysis revealed a deficit of €409 ± 1,717 per patient and an overall deficit for the hospital of €44,635. In 2017 period, the same evaluation indicated a deficit of €446 ± 1,316 per patient and an overall deficit for the hospital of €48,210. The cost of MD accounts for a significant share of total expenses. Conclusion The profitability for the cardiac rhythm activity at our facility was optimized between 2014 and 2017. The reliance on ambulatory care increased. However, the reduction in the expenses incurred did not increase the profitability for the facility. It was offset by a decrease in DRG tariffs. A flowchart-type structure based on these practices analyses for rhythmic disorder treatments was developed.